NVO vs OVID
NVO (NVO) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
NVO (NVO) common stock.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
NVO does not have a complete income-statement cache yet.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
NVO currently screens at market cap $0. OVID currently screens at market cap $23.5M.
Not investment advice. Open the NVO and OVID stock pages for the full models.
Not investment advice.